MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure
Year: 2014
Type: article
Source: Leukemia
DOI: 10.1038/leu.2014.6
Authors: M Agrawal, B Hanfstein, P Erben, D Wolf, T Ernst, A Fabarius, S Saussele, D Purkayastha, R C Woodman, W-K Hofmann, R Hehlmann, A Hochhaus, M C Müller
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2069668312